Hantz Financial Services’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
32,641
+24,633
| +308% | +$13.2M | 0.28% | 67 |
|
|
2025
Q1 | $3.36M | Buy |
8,008
+270
| +3% | +$113K | 0.06% | 253 |
|
|
2024
Q4 | $3.2M | Buy |
7,738
+800
| +12% | +$331K | 0.06% | 260 |
|
|
2024
Q3 | $3.51M | Sell |
6,938
-113
| -2% | -$57.1K | 0.06% | 254 |
|
|
2024
Q2 | $3.44M | Buy |
7,051
+1,407
| +25% | +$685K | 0.07% | 253 |
|
|
2024
Q1 | $3.05M | Sell |
5,644
-349
| -6% | -$188K | 0.06% | 276 |
|
|
2023
Q4 | $3.33M | Sell |
5,993
-320
| -5% | -$178K | 0.07% | 270 |
|
|
2023
Q3 | $2.76M | Sell |
6,313
-13
| -0.2% | -$5.68K | 0.07% | 266 |
|
|
2023
Q2 | $3.18M | Sell |
6,326
-97
| -2% | -$48.7K | 0.08% | 253 |
|
|
2023
Q1 | $3.21M | Buy |
6,423
+465
| +8% | +$233K | 0.09% | 242 |
|
|
2022
Q4 | $2.43M | Buy |
5,958
+5,932
| +22,815% | +$2.42M | 0.07% | 265 |
|
|
2022
Q3 | $8K | Sell |
26
-27
| -51% | -$8.31K | ﹤0.01% | 776 |
|
|
2022
Q2 | $19K | Sell |
53
-226
| -81% | -$81K | ﹤0.01% | 668 |
|
|
2022
Q1 | $153K | Sell |
279
-995
| -78% | -$546K | ﹤0.01% | 542 |
|
|
2021
Q4 | $839K | Sell |
1,274
-58
| -4% | -$38.2K | 0.02% | 388 |
|
|
2021
Q3 | $828K | Sell |
1,332
-38
| -3% | -$23.6K | 0.03% | 359 |
|
|
2021
Q2 | $865K | Buy |
1,370
+224
| +20% | +$141K | 0.03% | 339 |
|
|
2021
Q1 | $561K | Buy |
1,146
+289
| +34% | +$141K | 0.02% | 355 |
|
|
2020
Q4 | $428K | Buy |
857
+616
| +256% | +$308K | 0.02% | 341 |
|
|
2020
Q3 | $95K | Buy |
+241
| New | +$95K | ﹤0.01% | 437 |
|